SERMs in chemoprevention of breast cancer

This publication has 63 references indexed in Scilit:

• Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer
  Breast Cancer Research and Treatment, 2004
• A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
  New England Journal of Medicine, 2004
• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer
  New England Journal of Medicine, 2003
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Serum insulin-like growth factor-I and breast cancer
  International Journal of Cancer, 2000
• Circulating concentrations of insulin-like growth factor I and risk of breast cancer
  The Lancet, 1998
• Tumour biological features of BRCA1-induced breast and ovarian cancer
  European Journal Of Cancer, 1997
• Retinoids and Apoptosis: Implications for Cancer Chemoprevention and Therapy
  JNCI Journal of the National Cancer Institute, 1995
• Breast cancer susceptibility: a complex disease unravels
  Trends in Genetics, 1995
• Distribution of fenretinide in the mammary gland of breast cancer patients
  European Journal of Cancer and Clinical Oncology, 1991